The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 333:1638-1639 December 14, 1995 Number 24
NextNext

Magnesium Sulfate versus Phenytoin for the Prevention of Eclampsia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Lucas, M. J.
To the Editor: The study by Lucas et al. (July 27 issue)1 offered an opportunity to resolve a controversy in patient care that has divided neurologists and obstetricians for decades. However, their conclusion regarding the superiority of magnesium sulfate over phenytoin may have been influenced by several methodologic flaws. First, the loading dose of phenytoin was lower than the typical recommended dose of 18 to 20 mg per kilogram of body weight, and the reported serum levels when seizures occurred (<12.2 µg per milliliter in 8 of the 10 patients in whom eclampsia subsequently developed) are evidence of this less . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.